Real-World Effectiveness of Intravenous Belimumab on Clinical Outcomes in Patients With Systemic Lupus Erythematosus in Saudi Arabia: The OBSErve Observational Study
Real-world data from patients with SLE treated with IV belimumab in Saudi Arabia demonstrated clinical improvements and reductions in corticosteroid dose and HCRU. Although the low number of patients and lack of a control group limit interpretation, the similar findings to the other OBSErve studies support the effectiveness of belimumab for patients with SLE in Saudi Arabia.
Authors
- Ibrahim A. Al-Homood (ORCID: https://orcid.org/0000-0001-6391-6938)
- Ibrahim A. AlMaghlouth (ORCID: https://orcid.org/0000-0002-8176-287X)
- Saeed Noibi (ORCID: https://orcid.org/0009-0002-4075-7182)
- Munther A. Khamashta (ORCID: https://orcid.org/0000-0002-8927-6024)
- Tamer Elfishawy (ORCID: https://orcid.org/0009-0001-4307-569X)
- Debora França dos Santos (ORCID: https://orcid.org/0000-0003-3917-2291)
- Alhussain Asiri (ORCID: https://orcid.org/0000-0003-1524-8220)
- Juliana Queiroz (ORCID: https://orcid.org/0000-0002-1560-3598)
- Ali Alhammad (ORCID: https://orcid.org/0000-0002-7442-5015)
- Lindsey Teichman (ORCID: https://orcid.org/0000-0002-2600-9383)
- Mohamed Othman
- Alaa Mustafa
- H. Hamdy
Institutions
- King Saud Medical City (SA)
- King Fahd Medical City (SA)
- King Saud University (SA)
- King Fahad Specialist Hospital (SA)
- MODUL University Dubai (AE)
- King Fahad Hospital Jeddah (SA)
- Dubai Medical College (AE)
- GlaxoSmithKline (Brazil) (BR)
- Asir Central Hospital (SA)
- University of Business and Technology (SA)
Publication Details
- Journal
- Open Access Rheumatology Research and Reviews
- Published
- 2025-02-01
- DOI
- https://doi.org/10.2147/oarrr.s497802
- Primary Topic
- Systemic Lupus Erythematosus Research
- Type
- article
- Field-Weighted Citation Impact
- 0.00